COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01129180
Brief Title: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

First Submitted : May 17, 2010
First Submitted that Met QC Criteria : May 21, 2010
First Posted : May 24, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : December 2, 2013
Last Update Posted : December 3, 2013 (Estimate)